The provisions of Title I of Book III of this Part relating to the National Agency for the Safety of Medicines and Health Products established in Title II of Book III of the same Part shall apply within the limits of the provisions extended to New Caledonia and French Polynesia and subject to the adaptations provided for in this Chapter.
In other cases, the Agency may enter into agreements with the authorities of New Caledonia and French Polynesia.
Article L. 5311-1 is applicable in New Caledonia and French Polynesia in the version resulting from Order no. 2022-1086 of 29 July 2022.
Article L. 5312-3 is applicable there in the version resulting fromOrder no. 2022-1086 of 29 July 2022.
Article L. 5313-1 shall apply in its wording resulting fromOrder no. 2022-582 of 20 April 2022, subject to replacing the reference to Regulation (EU) 2017/745 with the reference to the rules applicable in mainland France pursuant to Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017.